Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
sizes decrease » size increase (Expand Search), scores decreased (Expand Search)
size increased » rate increased (Expand Search), use increased (Expand Search), age increased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
sizes decrease » size increase (Expand Search), scores decreased (Expand Search)
size increased » rate increased (Expand Search), use increased (Expand Search), age increased (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”
-
12
-
13
-
14
-
15
-
16
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.
Published 2025“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”
-
17
-
18
-
19
-
20